Literature DB >> 26628983

Interferon-λ1 suppresses invasion and enhances autophagy in human osteosarcoma cell.

Dongmei Gao1, Jun Zhao2, Xiuyi Li1, Yuanyuan Xia1, Yu Cai1, Jiwen Pan1, Hong Zhou1, Yong Fang1, Shouzhu Zhang1, He Wen1.   

Abstract

OBJECTIVE: The purpose of the present study was to determine whether type III IFN can modulate the autophagic response in human osteosarcoma cell.
METHODS: Human osteosarcoma cell were treated with Interferon-λ1. We investigated that Interferon-λ1 could inhibit the invasive ability of osteosarcoma cells by Matrigel invasion assay. Autophagy were assessed by acridine orange staining, MDC staining and Transmission electron microscopy.
RESULTS: In this study, we found that Interferon-λ1 could inhibit the invasive ability of osteosarcoma cells. Acridine orange staining and MDC staining showed that Interferon-λ1 triggered the accumulation of acidic vesicular and autolysosomes in osteosarcoma cell. The acridine orange osteosarcoma cell ratios were 3.6 ± 0.5%, 4.5 ± 0.8%, and 12.4 ± 1.7% after treatment with 1, 10, and 100 ng/mL Interferon-λ1 for 48 h. Osteosarcoma cell cells treated with 100 ng/mL Interferon-λ1 for 48 h developed autophagy some-like characteristics, including single or double-membrane vacuoles containing intact and degraded cellular debris.
CONCLUSIONS: Interferon-λ1 could inhibit the invasive ability of osteosarcoma cells. Autophagy can be induced in a dose-dependent manner by treatment with Interferon-λ1 in osteosarcoma cell.

Entities:  

Keywords:  Interferon-λ1; acridine orange; autophagy; transmission electron microscopy

Year:  2015        PMID: 26628983      PMCID: PMC4658872     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  13 in total

1.  Type III IFNs in pteropid bats: differential expression patterns provide evidence for distinct roles in antiviral immunity.

Authors:  Peng Zhou; Chris Cowled; Shawn Todd; Gary Crameri; Elena R Virtue; Glenn A Marsh; Reuben Klein; Zhengli Shi; Lin-Fa Wang; Michelle L Baker
Journal:  J Immunol       Date:  2011-01-28       Impact factor: 5.422

Review 2.  The four faces of autophagy: implications for cancer therapy.

Authors:  David A Gewirtz
Journal:  Cancer Res       Date:  2014-01-23       Impact factor: 12.701

Review 3.  Therapeutic targeting of autophagy in cancer. Part II: pharmacological modulation of treatment-induced autophagy.

Authors:  Anika Nagelkerke; Johan Bussink; Anneke Geurts-Moespot; Fred C G J Sweep; Paul N Span
Journal:  Semin Cancer Biol       Date:  2014-06-14       Impact factor: 15.707

Review 4.  Autophagy and cancer therapy.

Authors:  Andrew Thorburn; Douglas H Thamm; Daniel L Gustafson
Journal:  Mol Pharmacol       Date:  2014-02-26       Impact factor: 4.436

Review 5.  Interferon-λs: special immunomodulatory agents and potential therapeutic targets.

Authors:  Ya-wen Zheng; Hui Li; Jin-pu Yu; Hua Zhao; Shizhen Emily Wang; Xiu-bao Ren
Journal:  J Innate Immun       Date:  2012-11-30       Impact factor: 7.349

6.  Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression.

Authors:  Christopher R Bolen; Siyuan Ding; Michael D Robek; Steven H Kleinstein
Journal:  Hepatology       Date:  2014-02-18       Impact factor: 17.425

Review 7.  Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses.

Authors:  Mingcai Li; Xiaojin Liu; Yanchun Zhou; Shao Bo Su
Journal:  J Leukoc Biol       Date:  2009-04-30       Impact factor: 4.962

Review 8.  Novel type III interferons produce anti-tumor effects through multiple functions.

Authors:  Quanhai Li; Kiyoko Kawamura; Yuji Tada; Hideaki Shimada; Kenzo Hiroshima; Masatoshi Tagawa
Journal:  Front Biosci (Landmark Ed)       Date:  2013-06-01

Review 9.  A possible anticancer agent, type III interferon, activates cell death pathways and produces antitumor effects.

Authors:  Masatoshi Tagawa; Kiyoko Kawamura; Quanhai Li; Yuji Tada; Kenzo Hiroshima; Hideaki Shimada
Journal:  Clin Dev Immunol       Date:  2011-10-16

10.  Interferon-λ1 linked to a stabilized dimer of Fab potently enhances both antitumor and antiviral activities in targeted cells.

Authors:  Donglin Liu; Chien-Hsing Chang; Edmund A Rossi; Thomas M Cardillo; David M Goldenberg
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

View more
  2 in total

Review 1.  Osteosarcoma Overview.

Authors:  Brock A Lindsey; Justin E Markel; Eugenie S Kleinerman
Journal:  Rheumatol Ther       Date:  2016-12-08

2.  IFN-λ Modulates the Migratory Capacity of Canine Mammary Tumor Cells via Regulation of the Expression of Matrix Metalloproteinases and Their Inhibitors.

Authors:  Rafał Pingwara; Daria Kosmala; Natalia Woźniak; Arkadiusz Orzechowski; Joanna Mucha
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.